We are live on
!
Find out more
WT
Wellcome Trust Portfolio holdings
AUM
$9.01B
1-Year Est. Return
12.05%
This Fund
S&P 500
This Quarter
Est. Return
-14.09%
1 Year Est. Return
+12.05%
3 Year Est. Return
+59.66%
5 Year Est. Return
+58.12%
10 Year Est. Return
+403.84%
AUM
$5.59B
AUM Growth
-$1.88B
(-25%)
Cap. Flow
-$758M
Cap. Flow
% of AUM
-13.56%
Top 10 Holdings %
Top 10 Hldgs %
70.59%
Holding
24
New
4
Increased
3
Reduced
6
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VMW
VMware, Inc
VMW
|
+$141M |
| 2 |
Visa
V
|
+$105M |
| 3 |
Accenture
ACN
|
+$52M |
| 4 |
Itaú Unibanco
ITUB
|
+$32.4M |
| 5 |
Nike
NKE
|
+$29.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$411M |
| 2 |
Apple
AAPL
|
+$353M |
| 3 |
Bank of America
BAC
|
+$135M |
| 4 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$95M |
| 5 |
JPMorgan Chase
JPM
|
+$85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.2% |
| 2 | Financials | 26.44% |
| 3 | Consumer Discretionary | 24.2% |
| 4 | Communication Services | 11.96% |
| 5 | Healthcare | 4.69% |
Similar funds
RRAM
MERSOM
PEA
AMH
YCM
KPWS
SI
GRQ
Wellcome Trust's Q1 2020 Portfolio in Review
As of Q1 2020, Wellcome Trust held 24 positions worth $5.59B, down 25% from $7.47B the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Wellcome Trust withdrew a net $758M in Q1 2020, closing 1 position and reducing 6 holdings. Its most notable exit was Karuna Therapeutics, Inc. Common Stock, an estimated $95M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 31% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Wellcome Trust opened a new position in Visa worth $89.4M.
- Wellcome Trust's largest Q1 2020 buy was Visa: 555,000 shares worth $89.4M.
- Wellcome Trust added most to VMware, Inc in Q1 2020, an estimated $141M increase.
- Wellcome Trust's biggest Q1 2020 reduction was Microsoft, cutting an estimated $411M.
- Wellcome Trust fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2020, selling an estimated $95M.
- Wellcome Trust's ten largest holdings make up 71% of its $5.59B portfolio in Q1 2020.
- Wellcome Trust opened 4 new positions and closed 1 in Q1 2020.
- Wellcome Trust's portfolio value fell 25% quarter-over-quarter to $5.59B.
Based on Wellcome Trust's 13F filing for Q1 2020, filed 17 Apr 2020.